Selected article for: "acute follow and long covid"

Author: Lui, David Tak Wai; Lee, Chi Ho; Chow, Wing Sun; Lee, Alan Chun Hong; Tam, Anthony Raymond; Pang, Polly; Ho, Tip Yin; Fong, Carol Ho Yi; Law, Chun Yiu; Leung, Eunice Ka Hong; To, Kelvin Kai Wang; Tan, Kathryn Choon Beng; Woo, Yu Cho; Lam, Ching Wan; Hung, Ivan Fan Ngai; Lam, Karen Siu Ling
Title: Long COVID in Patients with Mild to Moderate Disease: Do Thyroid Function and Autoimmunity Play a Role?
  • Cord-id: 73q14gy0
  • Document date: 2021_7_6
  • ID: 73q14gy0
    Snippet: OBJECTIVE: Long COVID (LC) is an emerging global health issue. Fatigue is a common feature. Whether thyroid function and autoimmunity play a role is uncertain. We aimed to evaluate the prevalence and predictors of LC and the potential role of thyroid function and autoimmunity in LC. METHODS: We included consecutive adults without known thyroid disorder, admitted to a major COVID-19 centre for confirmed COVID-19 from July to December 2020 who had thyroid function tests (TFTs) and anti-thyroid ant
    Document: OBJECTIVE: Long COVID (LC) is an emerging global health issue. Fatigue is a common feature. Whether thyroid function and autoimmunity play a role is uncertain. We aimed to evaluate the prevalence and predictors of LC and the potential role of thyroid function and autoimmunity in LC. METHODS: We included consecutive adults without known thyroid disorder, admitted to a major COVID-19 centre for confirmed COVID-19 from July to December 2020 who had thyroid function tests (TFTs) and anti-thyroid antibodies measured on admission and at follow-up. LC was defined by the presence or persistence of symptoms upon follow-up. RESULTS: In total, 204 patients (median age: 55.0 years; 46.6% men) were reassessed at a median of 89 days (IQR: 69–99) after acute COVID-19. Forty-one (20.1%) had LC. Female (adjusted odds ratio [aOR] 2.48, p=0.018) and SARS-CoV-2 PCR cycle threshold value <25 on admission (aOR 2.84, p=0.012) independently predicted the occurrence of LC. Upon follow-up, most abnormal TFTs in acute COVID-19 resolved, and incident thyroid dysfunction was rare. Nonetheless, we observed incident anti-TPO (anti-thyroid peroxidase) positivity. While baseline or follow-up TFTs were not associated with the occurrence of LC, among 172 patients symptomatic in acute COVID-19, symptom resolution was more likely in those with positive anti-TPO upon follow-up (p=0.043). CONCLUSION: LC is common among COVID-19 survivors, with female and those with higher viral load in acute COVID-19 particularly vulnerable. The observation of incident anti-TPO positivity warrants further follow-up for thyroid dysfunction. Whether anti-TPO plays a protective role in LC remains to be elucidated.

    Search related documents:
    Co phrase search for related documents
    • abnormal chest and acute infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20
    • abnormal chest and acute sequelae: 1, 2
    • abnormal chest and admission oxygen requirement: 1
    • abnormal chest and long covid: 1, 2, 3, 4, 5, 6
    • abnormal chest and long term monitoring: 1
    • acute illness and long covid: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute illness and long term monitoring: 1, 2, 3
    • acute illness recovery and long covid: 1, 2, 3, 4, 5
    • acute infection and admission oxygen requirement: 1, 2, 3
    • acute infection and long covid: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute infection and long covid role: 1
    • acute infection and long term monitoring: 1, 2, 3, 4, 5, 6, 7
    • acute infection recovery and long covid: 1, 2, 3, 4, 5
    • acute sequelae and long covid: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute sequelae and long term monitoring: 1
    • additional concern and long covid: 1